Skip to content

KUREKraneShares MSCI All China Health Care Index ETF

Grow my money8y track recordRanked #1,347 of 3,055 in this goal

Tracks the price and yield performance of the MSCI China All Shares Health Care 10/40 Index.

By KraneShares · Launched 2018

Annual Cost

0.65%

#3,547 of 6,040 · average

Fund Size

$109M

#3,006 of 6,040 · mid-size

Return (1Y)

-8.4%

Track Record

8 years

#1,688 of 6,040 · established

Performance

Total-return NAV · USD
Growth of $10,000
$9,058-9.4%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Cap

Multi cap

Strategy

Index tracking

Index tracked

MSCI China All Shares Health Care 10/40 Index

Holdings

By weight

Concentration

Top 10 holdings = 55.2% of fundmoderately concentrated

INNOVENT BIOLOGICS, INC.
8.7%
BeOne Medicines AG
8.2%
WUXI BIOLOGICS (CAYMAN) INC.
6.6%
Akeso Inc
5.7%
WuXi AppTec Co., Ltd.
5.7%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
4.6%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
4.3%
SINO BIOPHARMACEUTICAL LIMITED
4.2%
CSPC PHARMACEUTICAL GROUP LIMITED
3.6%
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
3.6%

Asset allocation

Stocks
99.0%
Cash
1.0%

By sector

Healthcare
99.1%
Consumer Defensive
0.9%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
27.4%High

Year-on-year price swings

Max drawdown
-68.5%Severe

Worst peak-to-trough loss

Sharpe (3Y)
0.14Below average
Sortino (3Y)
0.20Moderate downside risk

Listing

Exchange
NYSE Arca

Full fund details

Objective
Tracks the price and yield performance of the MSCI China All Shares Health Care 10/40 Index.
Strategy
Invests primarily in foreign equity securities of Chinese companies in the healthcare sector, tracking the MSCI China All Shares Health Care 10/40 Index. Holds mid-cap and large-cap companies, using representative sampling when necessary.
Inception date
January 31, 2018
Fund family
KraneShares

Next steps

Save KURE to compare it with other funds, or start building a portfolio.

Data updated on 2026-09-18